HDGHF: AI 评分 36/100 — AI 分析 (4月 2026)

Haydale Graphene Industries plc specializes in the production, sale, and functionalization of graphene and other nanomaterials. The company serves diverse sectors, including aerospace, automotive, and medical, offering advanced materials and consulting services.

Key Facts: AI Score: 36/100 Sector: Basic Materials

公司概况

概要：

Haydale Graphene Industries plc focuses on graphene and nanomaterial solutions, serving industries like aerospace and automotive with advanced materials and services. Operating internationally from its UK headquarters, the company's negative profit and gross margins highlight financial challenges in a competitive specialty chemicals market.

HDGHF是做什么的？

Haydale Graphene Industries plc, established in 2010 and headquartered in Ammanford, UK, operates in the specialty chemicals sector, focusing on graphene and other nanomaterials. Originally named Innovative Carbon Limited, the company rebranded in March 2014 to reflect its focus on graphene technology. Haydale produces, sells, and functionalizes these materials, offering a range of products including inks, coatings, resins, fluids, and masterbatches for composites and polymers. Its product portfolio extends to masterbatch and pre-preg composites, elastomers, silicon carbide whiskers, and graphene-enhanced face masks under the ceramycGuard brand. The company also provides advanced consulting and testing services. Haydale serves a diverse range of industries, including aerospace, automotive, marine, medical, printing inks and coatings, and sports. Its international presence spans the United Kingdom, Europe, the United States, China, Thailand, South Korea, and Japan. Despite its innovative product offerings and broad market reach, Haydale faces significant financial challenges, reflected in its negative profit and gross margins.

HDGHF的投资论点是什么？

Haydale Graphene Industries plc presents a high-risk, high-reward investment profile within the specialty chemicals sector. The company's focus on graphene and nanomaterials positions it to capitalize on potential growth in advanced material applications across various industries. However, the company's negative profit margin of -1236.2% and gross margin of -46.6% indicate substantial financial challenges. A key value driver is the increasing adoption of graphene in aerospace, automotive, and medical sectors, potentially boosting demand for Haydale's products. Upcoming catalysts include potential partnerships and new product launches. Investors should closely monitor the company's ability to improve its financial performance and secure strategic collaborations to validate its long-term viability. The high beta of 2.05 suggests significant volatility.

HDGHF在哪个行业运营？

Haydale Graphene Industries plc operates within the specialty chemicals industry, which is characterized by innovation and the development of high-performance materials. The market for graphene and nanomaterials is growing, driven by demand from sectors such as aerospace, automotive, and electronics. Key trends include the increasing adoption of advanced materials for enhanced performance and sustainability. Competitors like AUTR, BSWGF, KVGOF, NSRPF, and RGVNF are also vying for market share. Haydale's success depends on its ability to differentiate its products, secure strategic partnerships, and improve its financial performance in a competitive landscape.

Chemicals - Specialty

Basic Materials

HDGHF有哪些增长机遇？

Expansion in the Aerospace Sector: The aerospace industry increasingly demands lightweight and high-strength materials, creating a significant opportunity for graphene-enhanced composites. Haydale can leverage its expertise in functionalizing graphene to develop customized solutions for aircraft components, potentially capturing a share of the growing aerospace materials market, estimated to reach $38.7 billion by 2028. Timeline: Ongoing, with potential for increased adoption over the next 3-5 years.
Penetration of the Automotive Market: Graphene-enhanced materials offer the potential to improve fuel efficiency and performance in automobiles. Haydale can focus on developing graphene-based additives for tires, coatings, and structural components. The global automotive materials market is projected to reach $447.6 billion by 2027, presenting a substantial opportunity for Haydale to increase its revenue. Timeline: Gradual adoption expected over the next 5-7 years.
Growth in the Medical Device Industry: Graphene's unique properties make it suitable for various medical applications, including biosensors, drug delivery systems, and antimicrobial coatings. Haydale can collaborate with medical device manufacturers to develop innovative products that leverage graphene's capabilities. The global medical device market is expected to reach $603.4 billion by 2028, offering a significant growth avenue for Haydale. Timeline: Development and regulatory approvals may take 3-5 years before widespread adoption.
Development of Advanced Coatings and Inks: Graphene-based coatings and inks offer enhanced durability, conductivity, and corrosion resistance. Haydale can target the printing, electronics, and construction industries with these advanced materials. The global market for specialty coatings is projected to reach $97.8 billion by 2025, providing a substantial opportunity for Haydale to expand its product portfolio and market reach. Timeline: Ongoing, with potential for near-term revenue generation.
Strategic Partnerships and Collaborations: Forming strategic alliances with leading companies in target industries can accelerate Haydale's growth and market penetration. Collaborating with established players can provide access to new markets, technologies, and distribution channels. These partnerships can also help Haydale secure funding for research and development and enhance its credibility in the market. Timeline: Ongoing, with potential for immediate and long-term benefits.

Market capitalization of $0.03 billion indicates a small-cap company with potential for growth but also higher risk.
Negative P/E ratio of -1.75 reflects current unprofitability, requiring careful evaluation of future earnings potential.
Profit Margin of -1236.2% signals significant financial challenges and the need for substantial operational improvements.
Gross Margin of -46.6% indicates that the cost of goods sold exceeds revenue, highlighting inefficiencies in production or pricing.
Beta of 2.05 suggests the stock is more volatile than the market, implying higher potential gains but also greater risk.

HDGHF提供哪些产品和服务？

Produces graphene and other nanomaterials.
Sells graphene and other nanomaterials.
Functionalizes graphene and other nanomaterials.
Offers inks and coatings for various applications.
Provides resins, fluids, and masterbatches for composites and polymers.
Supplies masterbatch and pre-preg composites and elastomers.
Offers silicon carbide whiskers.
Provides advanced consulting and test services.

HDGHF如何赚钱？

Manufacturing and selling graphene-enhanced materials.
Providing functionalization services to customize graphene properties.
Offering consulting and testing services related to nanomaterials.
Developing and selling graphene-based products like inks, coatings, and composites.

Aerospace industry for lightweight and high-strength materials.
Automotive industry for improved fuel efficiency and performance.
Marine industry for durable and corrosion-resistant materials.
Medical industry for biosensors, drug delivery systems, and antimicrobial coatings.
Printing inks and coating industry for enhanced durability and conductivity.
Sports industry for high-performance equipment.

Proprietary functionalization techniques for graphene.
Expertise in developing customized graphene solutions for specific applications.
Established relationships with customers in key industries.
Intellectual property portfolio related to graphene technologies.

什么因素可能推动HDGHF股价上涨？

Upcoming: Potential new product launches in the aerospace sector by Q4 2026, leveraging graphene-enhanced composites.
Ongoing: Increasing adoption of graphene in the automotive industry, driving demand for Haydale's materials.
Ongoing: Strategic partnerships with leading companies in target industries, expanding market reach.
Upcoming: Positive results from ongoing research and development efforts, leading to new applications for graphene.
Upcoming: Potential government funding or grants for graphene research and development in H1 2027.

HDGHF的主要风险是什么？

Ongoing: Intense competition from other nanomaterial companies, potentially impacting market share.
Potential: Fluctuations in raw material prices, affecting production costs and profitability.
Potential: Economic downturns affecting key industries, reducing demand for Haydale's products.
Potential: Regulatory challenges related to nanomaterials, increasing compliance costs.
Ongoing: Negative profit and gross margins, raising concerns about financial sustainability.

HDGHF的核心优势是什么？

Specialized expertise in graphene functionalization.
Diverse product portfolio serving multiple industries.
International presence with operations in key markets.
Strong focus on research and development.

HDGHF的劣势是什么？

Negative profit and gross margins.
Small market capitalization.
High beta indicating significant volatility.
Dependence on specific industries for revenue.

HDGHF有哪些机遇？

Growing demand for graphene in aerospace, automotive, and medical sectors.
Potential for strategic partnerships and collaborations.
Expansion into new markets and applications.
Development of innovative graphene-based products.

HDGHF面临哪些威胁？

Intense competition from other nanomaterial companies.
Fluctuations in raw material prices.
Economic downturns affecting key industries.
Regulatory challenges related to nanomaterials.

HDGHF的竞争对手是谁？

Autotech Ventures Acquisition Corp. — Focuses on investments in the transportation sector. — (AUTR)
Black Swan Graphene Inc. — Specializes in large-scale graphene production. — (BSWGF)
Kavango Resources PLC — Exploration company with diverse mineral projects. — (KVGOF)
NanoSphere Health Sciences Inc. — Focuses on nanoparticle delivery systems for pharmaceuticals. — (NSRPF)
Regen BioPharma Inc. — Developing regenerative medicine therapies. — (RGVNF)

Key Metrics

MoonshotScore: 36/100

Company Profile

CEO: Simon Andrew Turek
Headquarters: Ammanford, GB
Employees: 63
Founded: 2015

AI Insight

AI analysis pending for HDGHF

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Haydale Graphene Industries plc do?

Haydale Graphene Industries plc specializes in the production, sale, and functionalization of graphene and other nanomaterials. The company offers a range of products, including inks, coatings, resins, fluids, and masterbatches, serving industries such as aerospace, automotive, and medical. Haydale also provides advanced consulting and testing services, leveraging its expertise in graphene technology to develop customized solutions for specific applications. The company's business model focuses on providing high-performance materials and services to enhance the properties and performance of various products.

What do analysts say about HDGHF stock?

As of March 16, 2026, there is no readily available analyst consensus on HDGHF stock due to its OTC listing and small market capitalization. Key valuation metrics, such as the negative P/E ratio and profit margin, reflect current unprofitability. Growth considerations include the potential for increased adoption of graphene in key industries and the company's ability to secure strategic partnerships. Investors should conduct their own thorough research and consider the risks associated with investing in a small-cap, OTC-listed company with limited financial disclosure.

What are the main risks for HDGHF?

The main risks for Haydale Graphene Industries plc include intense competition from other nanomaterial companies, fluctuations in raw material prices, and economic downturns affecting key industries. The company's negative profit and gross margins raise concerns about its financial sustainability. Regulatory challenges related to nanomaterials could also increase compliance costs. Additionally, the OTC listing and limited financial disclosure add a layer of risk for investors, as it may be difficult to obtain timely and accurate information about the company's financial performance and operations.